Anatara Lifesciences
Brisbane
California
United States
44 articles about Anatara Lifesciences
-
Anatara’s gut-targeted dietary supplement completes preclinical testing, demonstrating it can treat inflammatory gastrointestinal disease and may promote mucosal healing
10/14/2019
Successful completion of the preclinical program has provided strong scientific proof that the GaRP dietary supplement has the potential to be game changing
-
Anatara Lifesciences Ltd (ASX:ANR) Quarterly Report
10/31/2018
Anatara Lifesciences is pleased to release its Appendix 4C for the quarter ending 30th September 2018. The Company's cash position at the end of the quarter stood at $7.1m.
-
Anatara Lifesciences Ltd (ASX:ANR) Formation of Product Development Advisory Board
10/23/2018
Anatara Lifesciences to announce the formation of its Product Development Advisory Board.
-
Anatara Lifesciences Ltd (ASX:ANR) 2018 Annual Report
10/10/2018
Anatara Lifesciences is pleased to release its Annual Report, for the year ended 30th June 2018.
-
Anatara Announces Exclusive Global License Agreement with Zoetis
5/15/2018
Agreement represents the achievement of a major milestone for Anatara and its shareholders
-
Anatara Lifesciences Presents at Australasian Pig Science Association Conference
11/21/2017
A single dose of Detach at weaning was as effective as in-feed ZnO in reducing diarrhoea and antibiotic treatments in piglets post-weaning compared to untreated piglets.
-
Anatara Lifesciences Investor Presentation This Week
10/19/2017
Anatara Lifesciences is pleased to release its latest institutional roadshow presentation and market update that will be delivered to investors this week by CEO - chairman, Dr Mel Bridges and Co-Founder and Chief Scientific Officer, Dr Tracey Mynott.
-
Anatara Lifesciences Pork CRC Options Extended By 12 Months
9/13/2017
-
Anatara Lifesciences And Zoetis To Negotiate Terms Of An International Detach Commercial Agreement
8/21/2017
-
Anatara Lifesciences Gold Coast Investment Showcase Investor Presentation
6/21/2017
-
Anatara Lifesciences Wilsons Equity Research Report Issued With Buy Rating
6/8/2017
-
Anatara Lifesciences Investor Update And R&D Tax Rebate
6/6/2017
-
Anatara Lifesciences ABC Video Program - Non-Antibiotic Treatment For Pigs
3/23/2017
-
Anatara Lifesciences Half Yearly Report And Accounts
2/23/2017
-
Anatara Lifesciences Receives Second Payment For Detach Under The Agreement With Zoetis
1/30/2017
-
Anatara Lifesciences Release: Company Research Report 'A Good Gut Feeling' By NDF Research
1/25/2017
-
Anatara Lifesciences Chairman's Address To Shareholders
11/15/2016
-
Anatara Lifesciences AGM Presentation
11/15/2016
-
Anatara Lifesciences Receives R&D Tax Refund
10/14/2016
-
Anatara Lifesciences Annual Report To Shareholders
10/14/2016